A Microfluidic In Vitro Three-Dimensional Dynamic Model of the Blood-Brain Barrier to Study the Transmigration of Immune Cells

被引:13
作者
Meena, Megha [1 ]
Vandormael, Robin [2 ]
De Laere, Maxime [3 ]
Pintelon, Isabel [4 ]
Berneman, Zwi [1 ,3 ]
Watts, Regan [2 ]
Cools, Nathalie [1 ,3 ]
机构
[1] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Fac Design Sci, Dept Prod Dev, B-2000 Antwerp, Belgium
[3] Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium
[4] Univ Antwerp, Lab Cell Biol & Histol, Fac Pharmaceut Biomed & Vet Sci, B-2610 Antwerp, Belgium
关键词
blood-brain barrier; central nervous system; endothelial cells; TripleB slides; microfluidic device; transendothelial electrical resistance; FITC-dextran permeability; P-glycoprotein; JUNCTION PROTEIN ZO-2; P-GLYCOPROTEIN FUNCTION; TIGHT JUNCTION; ENDOTHELIAL-CELLS; SHEAR-STRESS; IMMUNOFLUORESCENCE ASSAY; ELECTRICAL-RESISTANCE; PERMEABILITY; EXPRESSION; TRANSPORT;
D O I
10.3390/brainsci12101293
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To study the biodistribution of new chemical and biological entities, an in vitro model of the blood-brain barrier (BBB) may become an essential tool during early phases of drug discovery. Here, we present a proof-of-concept of an in-house designed three-dimensional BBB biochip designed by us. This three-dimensional dynamic BBB model consists of endothelial cells and astrocytes, co-cultured on opposing sides of a polymer-coated membrane under flow mimicking blood flow. Our results demonstrate a highly effective BBB as evidenced by (i) a 30-fold increase in transendothelial electrical resistance (TEER), (ii) a significantly higher expression of tight junction proteins, and (iii) the low FITC-dextran permeability of our technical solution as compared to a static in vitro BBB model. Importantly, our three-dimensional BBB model effectively expresses P-glycoprotein (Pg-p), a hallmark characteristic for brain-derived endothelial cells. In conclusion, we provide here a complete holistic approach and insight to the whole BBB system, potentially delivering translational significance in the clinical and pharmaceutical arenas.
引用
收藏
页数:23
相关论文
共 134 条
[1]   Blood-brain barrier structure and function and the challenges for CNS drug delivery [J].
Abbott, N. Joan .
JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) :437-449
[2]   Structure and function of the blood-brain barrier [J].
Abbott, N. Joan ;
Patabendige, Adjanie A. K. ;
Dolman, Diana E. M. ;
Yusof, Siti R. ;
Begley, David J. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25
[3]   Physiology of the blood-brain barrier and its consequences for drug transport to the brain [J].
Abbott, NJ .
DRUG TRANSPORT(ERS) AND THE DISEASED BRAIN, 2005, 1277 :3-18
[4]   Astrocyte-endothelial interactions and blood-brain barrier permeability [J].
Abbott, NJ .
JOURNAL OF ANATOMY, 2002, 200 (06) :629-638
[5]   Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery [J].
Aday, S. ;
Cecchelli, R. ;
Hallier-Vanuxeem, D. ;
Dehouck, M. P. ;
Ferreira, L. .
TRENDS IN BIOTECHNOLOGY, 2016, 34 (05) :382-393
[6]   Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery [J].
Alavijeh M.S. ;
Chishty M. ;
Qaiser M.Z. ;
Palmer A.M. .
NeuroRX, 2005, 2 (4) :554-571
[7]  
ARISAKA T, 1995, ANN NY ACAD SCI, V748, P543
[8]   Tight junctions and the regulation of gene expression [J].
Balda, Maria S. ;
Matter, Karl .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (04) :761-767
[9]   The blood-brain barrier: an overview - Structure, regulation, and clinical implications [J].
Ballabh, P ;
Braun, A ;
Nedergaard, M .
NEUROBIOLOGY OF DISEASE, 2004, 16 (01) :1-13
[10]   Shear stress and the endothelium [J].
Ballermann, BJ ;
Dardik, A ;
Eng, E ;
Liu, AL .
KIDNEY INTERNATIONAL, 1998, 54 :S100-S108